DEXAMETHASONE KRKA 4 mg/ml, solution injectable/pour perfusion — 20 ampoule(s) en verre jaune(brun) suremballée(s)/surpochée(s) PVC-Aluminium de 1 mL

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930204368
  • CIP7 3020436
  • CIS 62350477

What the source publishes

Holder
KRKA (SLOVENIE)
Active ingredients
PHOSPHATE SODIQUE DE DEXAMÉTHASONE, PHOSPHATE DE DEXAMÉTHASONE
Form
solution injectable ou pour perfusion
Package
20 ampoule(s) en verre jaune(brun) suremballée(s)/surpochée(s) PVC-Aluminium de 1 mL
Routes
infiltration, intraarticulaire, intralésionnelle, intramusculaire, intraveineuse, sous-conjonctivale
Administrative status
authorised
Supply regime
liste I
Marketing status
Déclaration de commercialisation
Authorised on
2020-04-30
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930204368
{
  "cis": "62350477",
  "cip7": "3020436",
  "form": "solution injectable ou pour perfusion",
  "name": "DEXAMETHASONE KRKA 4 mg/ml, solution injectable/pour perfusion — 20 ampoule(s) en verre jaune(brun) suremballée(s)/surpochée(s) PVC-Aluminium de 1 mL",
  "cip13": "3400930204368",
  "holder": "KRKA (SLOVENIE)",
  "routes": [
    "infiltration",
    "intraarticulaire",
    "intralésionnelle",
    "intramusculaire",
    "intraveineuse",
    "sous-conjonctivale"
  ],
  "holders": [
    "KRKA (SLOVENIE)"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": null,
  "authorisedOn": "2020-04-30",
  "compositions": [
    {
      "name": "PHOSPHATE SODIQUE DE DEXAMÉTHASONE",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "03675",
      "dosageReference": null,
      "pharmaceuticalElement": "solution"
    },
    {
      "name": "PHOSPHATE DE DEXAMÉTHASONE",
      "nature": "FT",
      "strength": "4 mg",
      "linkageNumber": "1",
      "substanceCode": "73377",
      "dosageReference": "une ampoule de 1 mL",
      "pharmaceuticalElement": "solution"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": null,
  "medicinePrice": null,
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "DEXAMETHASONE KRKA 4 mg/ml, solution injectable/pour perfusion",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-20",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "20 ampoule(s) en verre jaune(brun) suremballée(s)/surpochée(s) PVC-Aluminium de 1 mL",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [],
  "marketingDeclaredOn": "2020-12-23",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "PHOSPHATE SODIQUE DE DEXAMÉTHASONE",
    "PHOSPHATE DE DEXAMÉTHASONE"
  ],
  "authorisationProcedure": "Procédure décentralisée",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930204368"